Veterinary medicines: bovine somatotropine BST, placing on the market and administration (repeal. Decision 90/218/EEC)

In adopting the report by Mrs Hedwig KEPPELHOFF-WIECHERT (EPP/ED, D), the European Parliament approved the proposal concerning the placing on the market and the administration of bovine somatotropine (BST). Moreover, it requests that: - the Commission continues to follow the scientific research on the potential adverse effects on human health of dietary exposure to products derived from rBST-treated dairy cows and, if necessary, make recommendation for further preventive measures; - the Union's financial resources are not used, directly or indirectly, in order to support the manufacture, packaging or exportation of rBST.�